Statistical considerations for confirmatory clinical trials for similar biotherapeutic products.

@article{Njue2011StatisticalCF,
  title={Statistical considerations for confirmatory clinical trials for similar biotherapeutic products.},
  author={Catherine Njue},
  journal={Biologicals : journal of the International Association of Biological Standardization},
  year={2011},
  volume={39 5},
  pages={266-9}
}
For the purpose of comparing the efficacy and safety of a Similar Biotherapeutic Product (SBP) to a Reference Biotherapeutic Product (RBP), the "Guidelines on Evaluation of Similar Biotherapeutic Products (SBPs)" issued by the World Health Organisation (WHO), states that equivalence or non-inferiority studies may be acceptable. While in principle, equivalence trials are preferred, non-inferiority trials may be considered if appropriately justified, such as for a medicinal product with a wide… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
10 Citations
4 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-4 of 4 references

Active-controlled noninferiority/equivalence trials: methods and practice

  • IK Hwang
  • British Medical Journal
  • 2005
Highly Influential
5 Excerpts

Non inferiority trials. Current Controlled Trials in Cardiovascular Medicine 2000;1(1):19e21

  • SM Snapinn
  • 2000
1 Excerpt

Similar Papers

Loading similar papers…